BIOGEN INC. - COMMON STOCK

Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union

31 Jan 2025 06:30:52 By Nasdaq GlobeNewswire

FDA Approves LEQEMBI® (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease

26 Jan 2025 18:33:52 By Nasdaq GlobeNewswire

FDA and EMA Accept Applications for Higher Dose Regimen of Nusinersen in SMA

23 Jan 2025 07:30:54 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

22 Jan 2025 09:46:19 By NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

16 Jan 2025 09:45:18 By NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

15 Jan 2025 11:45:04 By NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

14 Jan 2025 12:44:54 By NetDania Notify

FDA Accepts LEQEMBI® (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease

13 Jan 2025 19:05:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

20 Dec 2024 09:45:32 By NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

19 Dec 2024 09:59:02 By NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

18 Dec 2024 15:07:02 By NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

16 Dec 2024 09:45:54 By NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

13 Dec 2024 09:49:29 By NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

20 Nov 2024 09:45:06 By NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

19 Nov 2024 09:45:08 By NetDania Notify

Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity

19 Nov 2024 01:00:14 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

18 Nov 2024 09:46:07 By NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

15 Nov 2024 10:03:11 By NetDania Notify

Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer’s Disease

14 Nov 2024 11:23:15 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

14 Nov 2024 09:45:06 By NetDania Notify